Gonçalves lab
@goncalveslab.bsky.social
Gonçalves Lab @TUDelft (CS @EEMCS_TUD). Research on Computational Molecular Biomedicine, Machine Learning, Oncology by @joanagoncalves.bsky.social et al. Website: https://goncalveslab.tudelft.nl
Thank you to everyone contributing to this great celebration! Promotor Marcel Reinders, paranymphs Kirti Biharie & Sander Goossens, the whole DBL lab ❤️, family+friends of Yasin, committee Aalt-Jan van Dijk, Boudewijn Lelieveldt, Jeroen de Ridder, Patrick Kemmeren, Wouter Kouw.
October 3, 2025 at 2:55 PM
Thank you to everyone contributing to this great celebration! Promotor Marcel Reinders, paranymphs Kirti Biharie & Sander Goossens, the whole DBL lab ❤️, family+friends of Yasin, committee Aalt-Jan van Dijk, Boudewijn Lelieveldt, Jeroen de Ridder, Patrick Kemmeren, Wouter Kouw.
TL;DR
Part I: anti-cancer therapy target discovery, synthetic lethality prediction (ELISL) & stratification of oncogene-addicted cohorts (Oncostratifier, collab Iorio's lab).
Part II: mitigation of selection bias in ML via diversity-guided self-training (DCAST, Metric-DST).
Part I: anti-cancer therapy target discovery, synthetic lethality prediction (ELISL) & stratification of oncogene-addicted cohorts (Oncostratifier, collab Iorio's lab).
Part II: mitigation of selection bias in ML via diversity-guided self-training (DCAST, Metric-DST).
October 3, 2025 at 2:55 PM
TL;DR
Part I: anti-cancer therapy target discovery, synthetic lethality prediction (ELISL) & stratification of oncogene-addicted cohorts (Oncostratifier, collab Iorio's lab).
Part II: mitigation of selection bias in ML via diversity-guided self-training (DCAST, Metric-DST).
Part I: anti-cancer therapy target discovery, synthetic lethality prediction (ELISL) & stratification of oncogene-addicted cohorts (Oncostratifier, collab Iorio's lab).
Part II: mitigation of selection bias in ML via diversity-guided self-training (DCAST, Metric-DST).